Stefano V. Gulla

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-KLRG1 antibodies
- Patent number 12,365,735
- Issue date Jul 22, 2025
- The Brigham & Women's Hospital, Inc.
- Stefano V Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating disorders associated with excess or unwanted ki...
- Patent number 12,139,541
- Issue date Nov 12, 2024
- Abcuro, Inc.
- Stefano Vincenzo Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant ROBO2 proteins, compositions, methods and uses thereof
- Patent number 11,970,524
- Issue date Apr 30, 2024
- Pfizer Inc.
- Stephen Berasi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Interferon beta antibodies and uses thereof
- Patent number 11,858,986
- Issue date Jan 2, 2024
- Pfizer Inc.
- Stefano V. Gulla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ROBO2 antibodies, compositions, methods and uses thereof
- Patent number 11,365,253
- Issue date Jun 21, 2022
- Pfizer Inc.
- Stephen Berasi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
KLRG1 antagonist signaling therapy
- Patent number 11,339,222
- Issue date May 24, 2022
- The Brigham & Women's Hospital, Inc.
- Steven Greenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Killer cell lectin-like receptor subfamily G member 1 (KLRG1) deple...
- Patent number 11,180,561
- Issue date Nov 23, 2021
- Abcuro, Inc.
- Stefano Vincenzo Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant ROBO2 proteins, compositions, methods and uses thereof
- Patent number 10,906,955
- Issue date Feb 2, 2021
- Pfizer Inc.
- Stephen Berasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interferon beta antibodies and uses thereof
- Patent number 10,829,553
- Issue date Nov 10, 2020
- Pfizer Inc.
- Stefano V. Gulla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CD8-TARGETED IL-12 FUSION PROTEINS
- Publication number 20250101107
- Publication date Mar 27, 2025
- REPERTOIRE IMMUNE MEDICINES, INC.
- Jonathan D. NARDOZZI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING DISORDERS ASSOCIATED WITH EXCESS OR UNWANTED KI...
- Publication number 20250101114
- Publication date Mar 27, 2025
- Abcuro, Inc.
- Stefano Vincenzo Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...
- Publication number 20250101112
- Publication date Mar 27, 2025
- Abcuro, Inc.
- Stefano Vincenzo GULLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD21 ANTIBODIES AND USES THEREOF
- Publication number 20240376225
- Publication date Nov 14, 2024
- The Children's Medical Center Corporation
- Hulian GAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-KLRG1 ANTIBODIES
- Publication number 20240174754
- Publication date May 30, 2024
- Abcuro, Inc.
- Stefano V. GULLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON BETA ANTIBODIES AND USES THEREOF
- Publication number 20240174742
- Publication date May 30, 2024
- Pfizer Inc.
- Stefano V. Gulla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...
- Publication number 20220089747
- Publication date Mar 24, 2022
- Abcuro, Inc.
- Stefano Vincenzo Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-KLRG1 ANTIBODIES
- Publication number 20210347899
- Publication date Nov 11, 2021
- Abcuro, Inc.
- Stefano V GULLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND USES THEREOF
- Publication number 20210214414
- Publication date Jul 15, 2021
- Pfizer Inc.
- Stephen Berasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON BETA ANTIBODIES AND USES THEREOF
- Publication number 20210163588
- Publication date Jun 3, 2021
- Pfizer Inc.
- Stefano V. Gulla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...
- Publication number 20200325233
- Publication date Oct 15, 2020
- Abcuro, Inc.
- Stefano Vincenzo Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ROBO2 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF
- Publication number 20200157212
- Publication date May 21, 2020
- Pfizer Inc.
- Stephen Berasi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
KLRG1 SIGNALING THERAPY
- Publication number 20190292264
- Publication date Sep 26, 2019
- THE BRIGHAM AND WOMEN'S HOSPITAL
- Steven Greenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KLRG1 DEPLETION THERAPY
- Publication number 20190194333
- Publication date Jun 27, 2019
- The Brigham & Women's Hospital, Inc.
- Steven Greenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KLRG1 SIGNALING THERAPY
- Publication number 20190085083
- Publication date Mar 21, 2019
- THE BRIGHAM AND WOMEN'S HOSPITAL
- Steven Greenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND USES THEREOF
- Publication number 20180346542
- Publication date Dec 6, 2018
- Pfizer Inc.
- Stephen Berasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON BETA ANTIBODIES AND USES THEREOF
- Publication number 20170313769
- Publication date Nov 2, 2017
- Pfizer Inc.
- Stefano V. Gulla
- C07 - ORGANIC CHEMISTRY

Stefano V. Gulla

Person

Patents Grantslast 30 patents

Anti-KLRG1 antibodies

Methods of treating disorders associated with excess or unwanted ki...

Recombinant ROBO2 proteins, compositions, methods and uses thereof

Interferon beta antibodies and uses thereof

Anti-ROBO2 antibodies, compositions, methods and uses thereof

KLRG1 antagonist signaling therapy

Killer cell lectin-like receptor subfamily G member 1 (KLRG1) deple...

Recombinant ROBO2 proteins, compositions, methods and uses thereof

Interferon beta antibodies and uses thereof

Patents Applicationslast 30 patents

CD8-TARGETED IL-12 FUSION PROTEINS

METHODS OF TREATING DISORDERS ASSOCIATED WITH EXCESS OR UNWANTED KI...

KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...

CD21 ANTIBODIES AND USES THEREOF

ANTI-KLRG1 ANTIBODIES

INTERFERON BETA ANTIBODIES AND USES THEREOF

KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...

ANTI-KLRG1 ANTIBODIES

RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND USES THEREOF

INTERFERON BETA ANTIBODIES AND USES THEREOF

KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...

ANTI-ROBO2 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF

KLRG1 SIGNALING THERAPY

KLRG1 DEPLETION THERAPY

KLRG1 SIGNALING THERAPY

RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND USES THEREOF

INTERFERON BETA ANTIBODIES AND USES THEREOF